News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
1–5
Matches
5
Sources here
1
Companies here
1
Search results Stored financial headlines

Active search

5 matching headlines

Ticker or company: GSKNMain company stories
Clear
Latest

finance.yahoo.com Earnings

Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era?

On July 28, GSK plc (NYSE:GSK) reported its second-quarter financial results, delivering strong core operational performance and showcasing steady commercial momentum. The firm's total Q2 turnover reached £8.4 billion, marking a 5% increase year-over-year at constant exchange rates (CER), while Core operating profit climbed 7% CER to £2.80 billion and Core EPS rose 9% CER to 50.5p. Growth …

Main company 🇲🇽 Mexico
Read at finance.yahoo.com
Sharemaestro market context Price below Trend Line 52 weeks +21.9% · Next-week setup negative 41.8% GSKN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Just inNext headlines
finance.yahoo.com Earnings Main company 🇲🇽 Mexico

GSK PLC (GSK) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Accelerated Pipeline ...

This article first appeared on GuruFocus. Revenue: Q2 sales up 5% to more than GBP8.4 billion. Core Operating Profit: Grew 7%. Core Earnings Per Share (EPS): Up 9%. Cash Generation: Positive at GBP4.3 billion. Q2 Dividend: 17p. Gross Margin: Improved 250 basis points due …

GSKN main company
Sharemaestro market context Price below Trend Line 52 weeks +21.9% · Next-week setup negative 41.8% GSKN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Market update Main company 🇲🇽 Mexico

New survey reveals Canadians underestimate chronic hepatitis B and its link to liver cancer

Nearly 9 in 10 Canadians have little to no awareness of chronic hepatitis B (CHB) Only 31% rank CHB as a high cancer risk, revealing a significant gap between perception and reality Just 14% report to have been tested for CHB, yet CHB causes …

GSKN main company
Sharemaestro market context Price below Trend Line 52 weeks +21.9% · Next-week setup negative 41.8% GSKN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

finance.yahoo.com Earnings Main company 🇲🇽 Mexico

GSK Lands FDA Approval for Nuvalent-Acquired Jideytro for NSCLC

GSK plc GSK announced that the FDA has approved Jideytro (zidesamtinib) for previously treated ROS1-positive non-small cell lung cancer (NSCLC). Jideytro was added as a late-stage candidate to GSK's oncology portfolio through the recently closed acquisition of Nuvalent. Jideytro is a next-generation, highly selective …

GSKN main company
Sharemaestro market context Price below Trend Line 52 weeks +21.9% · Next-week setup negative 41.8% GSKN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
finance.yahoo.com Regulatory and legal Main company 🇲🇽 Mexico

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

Approval based on ARROS-1 phase I/II trial demonstrating meaningful and durable responses in patients with locally advanced or metastatic disease1 Next-generation design aims to address key efficacy and tolerability challenges of treating ROS1-positive NSCLC GSK's first approval in lung cancer, part of a growing …

GSKN main company
Sharemaestro market context Price below Trend Line 52 weeks +21.9% · Next-week setup negative 41.8% GSKN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context